Case Report: Primary sciatic leiomyosarcoma in a patient with neurofibromatosis type 1
By
Longgang Chen
Meiling Xu
Kai Cheng
Lingya Cui
Xuefei Mou
Changhui Li
May 7, 2026
Clinical Report: Primary Leiomyosarcoma of the Sciatic Nerve in a Neurofibromatosis Type 1 Patient
Overview {'follow_up': 'Specify if any long-term monitoring is planned beyond six months.'}
Background {'details': 'Add implications of LMS in NF1 patients and the rarity of such cases.'}
Data Highlights {'qualitative_data': 'Consider adding qualitative data or case comparisons.'}
Key Findings {'imaging_results': 'Ensure all findings are supported by data from the case report.'}
Clinical Implications {'multidisciplinary_approach': 'Expand on the roles of different specialists.'}
Conclusion {'significance': 'Reiterate the significance of this case in NF1 management.'}
References
Springer, Progress in Multidisciplinary Surgical Strategies for Primary Spinal Sarcomas, 2024 -- Findings from a Retrospective Case Series on Patient Outcomes and Survival Rates Springer, Journal of Neuro-Oncology, 2009 -- Treatment of Secondary Brain Stem Fibrosarcoma with Cyclophosphamide and Imatinib Springer, Acta Neuropathologica, 2023 -- Somatic mosaicism of SOX10 indel mutations is associated with a specific variant of segmental schwannomatosis Springer, Acta Neuropathologica, 2026 -- FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational study Oxford Academic, Bayesian approach for diagnostic accuracy of malignant peripheral nerve sheath tumors: a systematic review and meta-analysis, Neuro-Oncology, 2023 PubMed, NCCN Guidelines® Insights: Soft Tissue Sarcoma, Version 1.2025 Bayesian approach for diagnostic accuracy of malignant peripheral nerve sheath tumors: a systematic review and meta-analysis | Neuro-Oncology | Oxford Academic NCCN Guidelines® Insights: Soft Tissue Sarcoma, Version 1.2025 - PubMed The new england
